Nasdaq · SIC 3842
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally. invasive approach.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $4.4B | $5.7B | $6.2B | $7.1B | $8.4B | $10.1B |
| Gross profit | $2.9B | $4.0B | $4.2B | $4.7B | $5.6B | $6.6B |
| Operating income | $1.0B | $1.8B | $1.6B | $1.8B | $2.3B | $2.9B |
| Net income | $1.1B | $1.7B | $1.3B | $1.8B | $2.3B | $2.9B |
| Diluted EPS | $2.94 | $4.66 | $3.65 | $5.03 | $6.42 | $7.87 |
| Operating cash flow | $1.5B | $2.1B | $1.5B | $1.8B | $2.4B | $3.0B |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | 65.6% | 69.3% | 67.4% | 66.4% | 67.5% | 66.0% |
| Operating margin | 24.1% | 31.9% | 25.3% | 24.8% | 28.1% | 29.3% |
| Net margin | 24.3% | 29.9% | 21.3% | 25.2% | 27.8% | 28.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0B | $2.0B | $2.4B | $2.3B | $2.4B | $2.5B | $2.9B | $2.8B |
| Gross profit | $1.4B | $1.4B | $1.6B | $1.5B | $1.6B | $1.7B | $1.9B | $1.8B |
| Operating income | $567.3M | $577.3M | $734.9M | $578.1M | $743.4M | $759.7M | $864.3M | $855.3M |
| Net income | $526.9M | $565.1M | $685.7M | $698.4M | $658.4M | $704.4M | $794.8M | $821.5M |
| Diluted EPS | $1.46 | $1.56 | $1.89 | $1.92 | $1.81 | $1.95 | $2.19 | $2.28 |
| Operating cash flow | $620.5M | $706.5M | $822.6M | $581.6M | $715.4M | $841.0M | $892.5M | $911.9M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 68.3% | 67.4% | 68.0% | 64.7% | 66.3% | 66.4% | 66.4% | 66.1% |
| Operating margin | 28.2% | 28.3% | 30.4% | 25.7% | 30.5% | 30.3% | 30.2% | 30.9% |
| Net margin | 26.2% | 27.7% | 28.4% | 31.0% | 27.0% | 28.1% | 27.7% | 29.6% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-10 | Rosa David J.· Chief Executive Officer (CEO) | Tax withholding | 947 | $411.55 | $389,737.85 | filing |
| 2026-07-10 | Rosa David J.· Chief Executive Officer (CEO) | Option exercise | 1,910 | $0.00 | $0.00 | filing |
| 2026-06-12 | Brosius Mark· EVP & Chief Mfg and Supply Cha | Sale | 25 | $414.13 | $10,353.25 | filing |
| 2026-06-11 | Brosius Mark· EVP & Chief Mfg and Supply Cha | Sale | 23 | $412.16 | $9,479.68 | filing |
| 2026-06-10 | Rosa David J.· Chief Executive Officer (CEO) | Tax withholding | 674 | $426.61 | $287,535.14 | filing |
| 2026-06-10 | LOEB GARY· EVP & Chief Legal and Complian | Sale | 400 | $424.14 | $169,656.00 | filing |
| 2026-06-10 | Brosius Mark· EVP & Chief Mfg and Supply Cha | Sale | 23 | $424.14 | $9,755.22 | filing |
| 2026-06-10 | Rosa David J.· Chief Executive Officer (CEO) | Option exercise | 1,358 | $0.00 | $0.00 | filing |
| 2026-06-09 | Brosius Mark· EVP & Chief Mfg and Supply Cha | Sale | 23 | $421.13 | $9,685.99 | filing |
| 2026-06-08 | Brosius Mark· EVP & Chief Mfg and Supply Cha | Sale | 23 | $420.12 | $9,662.76 | filing |
| 2026-06-01 | Jeddi Iman· SVP & GM da Vinci Platforms & | Sale | 5,625 | $420.55 | $2.4M | filing |
| 2026-06-01 | Jeddi Iman· SVP & GM da Vinci Platforms & | Option exercise | 5,625 | $77.00 | $433,118.81 | filing |
| 2026-05-22 | Brosius Mark· EVP & Chief Mfg and Supply Cha | Sale | 18 | $439.80 | $7,916.40 | filing |
| 2026-05-21 | Brosius Mark· EVP & Chief Mfg and Supply Cha | Sale | 18 | $446.04 | $8,028.72 | filing |
| 2026-05-20 | Brosius Mark· EVP & Chief Mfg and Supply Cha | Sale | 18 | $440.38 | $7,926.84 | filing |
| 2026-05-19 | Brosius Mark· EVP & Chief Mfg and Supply Cha | Sale | 18 | $440.70 | $7,932.60 | filing |
| 2026-05-18 | Brosius Mark· EVP & Chief Mfg and Supply Cha | Sale | 18 | $422.47 | $7,604.46 | filing |
| 2026-05-11 | LOEB GARY· EVP & Chief Legal and Complian | Sale | 400 | $446.95 | $178,780.00 | filing |
| 2026-04-30 | Reed Monica P | Option exercise | 531 | $0.00 | $0.00 | filing |
| 2026-04-30 | NACHTSHEIM JAMI K | Option exercise | 531 | $0.00 | $0.00 | filing |
| 2026-04-30 | Leonard Keith R | Option exercise | 531 | $0.00 | $0.00 | filing |
| 2026-04-30 | Ladd Amy L | Option exercise | 531 | $0.00 | $0.00 | filing |
| 2026-04-30 | Kolli Sreelakshmi | Option exercise | 531 | $0.00 | $0.00 | filing |
| 2026-04-30 | Johnson Amal M | Option exercise | 531 | $0.00 | $0.00 | filing |
| 2026-04-30 | CHEW LEWIS | Option exercise | 531 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.